ALKERMES | ALKS - Eps Utile Per Azione

Prezzo Delle Azioni
33.70
Cambio Giornaliero
-0.01 -0.03%
Mensile
-4.69%
Annuale
10.20%
Q2 Previsione
32.32

Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 -0.4 0.13 May/05
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28
FY2025Q2 Jun/2025 0.52 0.39 0.72 Jul/29
FY2025Q1 Mar/2025 0.13 0.39 0.43 May/01




Eps Cambiamento Data
AbbVie USD 2.65 0.06 2026-03
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
ALKERMES USD 0.29 0.2 2025-12
Amgen USD 5.15 0.14 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Gilead Sciences USD 1.86 0.61 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
J&J USD 2.7 0.24 2026-03
Malin Corporation EUR -0.06 0.1 2023-12
Merck USD -1.28 3.32 2026-03
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Otsuka Holdings JPY 186.31 62.06 2026-03
Ovoca Bio EUR -0.06 0.01 2025-06
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Vertex Pharmaceuticals USD 5.03 0.23 2025-12